K211059 is an FDA 510(k) clearance for the CereFlow™ V1.2. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).
Submitted by Translational Mri, LLC (Los Angeles, US). The FDA issued a Cleared decision on March 31, 2023, 721 days after receiving the submission on April 9, 2021.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.
| 510(k) Number | K211059 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | April 09, 2021 |
| Decision Date | March 31, 2023 |
| Days to Decision | 721 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | LLZ - System, Image Processing, Radiological |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 892.2050 |